Tina's Wish Benefit Raises $1.4M for Early Detection Ovarian Cancer Research

Annual Dinner Honors the Memory of Former Bankruptcy Court Chief Judge Tina Brozman and marks the 7th Year of Raising Funds for the Early Detection and Prevention of Ovarian Cancer

News provided by

The Honorable Tina Brozman Foundation for Ovarian Cancer Research

Sep 24, 2015, 10:05 ET

NEW YORK, Sept. 24, 2015 /PRNewswire/ -- The legal and financial communities came together once again during Ovarian Cancer Awareness Month to raise $1.4M for The Honorable Tina Brozman Foundation for Ovarian Cancer Research (Tina's Wish) at its annual benefit dinner held at the American Museum of Natural History.

Since its inception seven years ago, Tina's Wish has become the third largest private funding source dedicated to early detection ovarian cancer research.

The Tina's Wish 7th Annual Benefit Dinner raised $1.4M for early detection ovarian cancer research.

This year's dinner honored Tim Coleman, Senior Managing Director and Head of the Restructuring and Reorganization group at PJT Partners/Blackstone.

"As someone who has strongly believed in this Foundation's mission and capabilities from the beginning, it is truly satisfying to continue to watch Tina's Wish exceed my expectations," said Tim Coleman. "The cure exists. The issue is detection."

The evening included an Ovarian Cancer Medical Update from Tina's Wish grant recipient and Chair of the Tina's Wish Scientific Advisory Board, Douglas A. Levine M.D., Memorial Sloan Kettering Cancer Center.

"The goal of our research consortium is to bring together researchers from different academic institutions and to work together on a common set of human tissue specimens in order to identify novel biomarkers that can be used in the early detection of ovarian cancer," said Douglas A. Levine, M.D. "It is my true belief that in my professional career we will be successful in detecting ovarian cancer early."

The American Cancer Society estimates that in 2015 in the United States, approximately 21,290 women will receive a new diagnosis of ovarian cancer and roughly 14,180 women will die from ovarian cancer. On average, only 27 percent of patients diagnosed during Stage III/IV will survive for five years, compared to 92 percent of women diagnosed during Stage I, demonstrating that tools for early detection are critical to changing the global impact of the disease.

Tina's Wish is recognizing Ovarian Cancer Awareness Month through their #TealForTinasWish social media contest. Participants post a photograph of someone wearing teal on Facebook, Instagram or Twitter and include #TealForTinasWish. The contest winner will receive a teal Fitbit.

For more information, please visit tinaswish.org.

Contact: Beverly Wolfer
Tina's Wish
212.880.5757
[email protected]

Photo - http://photos.prnewswire.com/prnh/20150923/270210

SOURCE The Honorable Tina Brozman Foundation for Ovarian Cancer Research